More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found.

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

Taken together, in vitro as well as in vivo experiments in several follicular cell-derived and medullary thyroid cancer cell lines have clearly demonstrated a therapeutic effect of the HSV-tk/GCV ...

GLP-1 receptor agonist labels in the U.S. (although not in Europe) have a black box warning about an increased risk for thyroid C-cell tumors seen in rats and mice. It has been difficult to ...

As expected, exenatide LAR has a similar side-effect profile to Byetta. However, exenatide LAR produced thyroid C-cell cancers in rats, an effect that was statistically significant in females at ...

and David C. Seldin Professor of Medicine at BU Chobanian and Avedesian School of Medicine. "This study brings us one step ...

Thyroid cancer is classified based on the types of cells found in the tumor. Most thyroid cancers are slow-growing, and some can be aggressive and according to Dr. Chery, the most common types of ...

Unless you have one that isn’t functioning properly, you probably haven’t given any thought to your thyroid gland today. Well ...

Sernova’s Cell Pouch bio-hybrid organ, in combination with autologous thyroid cell therapy, aims to restore natural thyroid function by providing a long-term, stable, and physiological solution ...